View in EDS

A Combination of Epigenetic BET and CDK9 Inhibitors for Treatment of Human Melanoma.

Saved in:
Bibliographic Details
Title: A Combination of Epigenetic BET and CDK9 Inhibitors for Treatment of Human Melanoma.
Authors: Emran AA; Melanoma Immunology and Oncology Program, The Centenary Institute, Royal Prince Alfred Hospital, The University of Sydney, Camperdown, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, Australia., Tseng HY; Melanoma Immunology and Oncology Program, The Centenary Institute, Royal Prince Alfred Hospital, The University of Sydney, Camperdown, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, Australia., Gunatilake D; Melanoma Immunology and Oncology Program, The Centenary Institute, Royal Prince Alfred Hospital, The University of Sydney, Camperdown, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, Australia., Cook SJ; Melanoma Immunology and Oncology Program, The Centenary Institute, Royal Prince Alfred Hospital, The University of Sydney, Camperdown, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, Australia., Ahmed F; Melanoma Immunology and Oncology Program, The Centenary Institute, Royal Prince Alfred Hospital, The University of Sydney, Camperdown, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, Australia., Wang S; Centre for Drug Discovery and Development, Cancer Research Institute, University of South Australia, Adelaide, Australia., Hersey P; Melanoma Immunology and Oncology Program, The Centenary Institute, Royal Prince Alfred Hospital, The University of Sydney, Camperdown, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, Australia., Gallagher SJ; Melanoma Immunology and Oncology Program, The Centenary Institute, Royal Prince Alfred Hospital, The University of Sydney, Camperdown, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, Australia., Tiffen JC; Melanoma Immunology and Oncology Program, The Centenary Institute, Royal Prince Alfred Hospital, The University of Sydney, Camperdown, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, Australia. Electronic address: j.tiffen@centenary.org.au.
Source: The Journal of investigative dermatology [J Invest Dermatol] 2021 Sep; Vol. 141 (9), pp. 2238-2249.e12. Date of Electronic Publication: 2021 Mar 26.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 0426720 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-1747 (Electronic) Linking ISSN: 0022202X NLM ISO Abbreviation: J Invest Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33781756
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A Combination of Epigenetic BET and CDK9 Inhibitors for Treatment of Human Melanoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Emran+AA%22">Emran AA</searchLink>; Melanoma Immunology and Oncology Program, The Centenary Institute, Royal Prince Alfred Hospital, The University of Sydney, Camperdown, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Tseng+HY%22">Tseng HY</searchLink>; Melanoma Immunology and Oncology Program, The Centenary Institute, Royal Prince Alfred Hospital, The University of Sydney, Camperdown, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Gunatilake+D%22">Gunatilake D</searchLink>; Melanoma Immunology and Oncology Program, The Centenary Institute, Royal Prince Alfred Hospital, The University of Sydney, Camperdown, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Cook+SJ%22">Cook SJ</searchLink>; Melanoma Immunology and Oncology Program, The Centenary Institute, Royal Prince Alfred Hospital, The University of Sydney, Camperdown, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Ahmed+F%22">Ahmed F</searchLink>; Melanoma Immunology and Oncology Program, The Centenary Institute, Royal Prince Alfred Hospital, The University of Sydney, Camperdown, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Wang+S%22">Wang S</searchLink>; Centre for Drug Discovery and Development, Cancer Research Institute, University of South Australia, Adelaide, Australia.<br /><searchLink fieldCode="AU" term="%22Hersey+P%22">Hersey P</searchLink>; Melanoma Immunology and Oncology Program, The Centenary Institute, Royal Prince Alfred Hospital, The University of Sydney, Camperdown, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Gallagher+SJ%22">Gallagher SJ</searchLink>; Melanoma Immunology and Oncology Program, The Centenary Institute, Royal Prince Alfred Hospital, The University of Sydney, Camperdown, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Tiffen+JC%22">Tiffen JC</searchLink>; Melanoma Immunology and Oncology Program, The Centenary Institute, Royal Prince Alfred Hospital, The University of Sydney, Camperdown, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, Australia. Electronic address: j.tiffen@centenary.org.au.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220426720%22">The Journal of investigative dermatology</searchLink> [J Invest Dermatol] 2021 Sep; Vol. 141 (9), pp. 2238-2249.e12. <i>Date of Electronic Publication: </i>2021 Mar 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0426720 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1523-1747 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220022202X%22">0022202X </searchLink><i>NLM ISO Abbreviation: </i>J Invest Dermatol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33781756
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jid.2020.12.038
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2238
    Titles:
      – TitleFull: A Combination of Epigenetic BET and CDK9 Inhibitors for Treatment of Human Melanoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Emran AA
      – PersonEntity:
          Name:
            NameFull: Tseng HY
      – PersonEntity:
          Name:
            NameFull: Gunatilake D
      – PersonEntity:
          Name:
            NameFull: Cook SJ
      – PersonEntity:
          Name:
            NameFull: Ahmed F
      – PersonEntity:
          Name:
            NameFull: Wang S
      – PersonEntity:
          Name:
            NameFull: Hersey P
      – PersonEntity:
          Name:
            NameFull: Gallagher SJ
      – PersonEntity:
          Name:
            NameFull: Tiffen JC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2021 Sep
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1523-1747
          Numbering:
            – Type: volume
              Value: 141
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: The Journal of investigative dermatology
              Type: main
ResultId 1